Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Lind

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Plos One|February 5, 2019
The Copenhagen Triage Algorithm is non-inferior to a traditional triage algorithm: A cluster-randomized studyRasmus Bo Hasselbalch, Mia Pries-Heje, Martin Schultz, et al.
Clinical Biochemistry|December 18, 2019
Abnormal routine blood tests as predictors of mortality in acutely admitted patientsRasmus Roenhoej Rønhøj, Rasmus B Hasselbalch, Martin Schultz, et al.
BMC Infectious Diseases|February 11, 2025
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trialToby J L Humphrey, Wendi Qian, Michael Chen-Xu, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|August 30, 2018
Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)Martin Schultz, Line Jee Hartmann Rasmussen, Malene H Andersen, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Plos One|February 5, 2019
The Copenhagen Triage Algorithm is non-inferior to a traditional triage algorithm: A cluster-randomized studyRasmus Bo Hasselbalch, Mia Pries-Heje, Martin Schultz, et al.
Clinical Biochemistry|December 18, 2019
Abnormal routine blood tests as predictors of mortality in acutely admitted patientsRasmus Roenhoej Rønhøj, Rasmus B Hasselbalch, Martin Schultz, et al.
BMC Infectious Diseases|February 11, 2025
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trialToby J L Humphrey, Wendi Qian, Michael Chen-Xu, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|August 30, 2018
Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)Martin Schultz, Line Jee Hartmann Rasmussen, Malene H Andersen, et al.
Pageof 3